These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31602204)

  • 21. Lung cancer mutation profile of EGFR, ALK, and KRAS: Meta-analysis and comparison of never and ever smokers.
    Chapman AM; Sun KY; Ruestow P; Cowan DM; Madl AK
    Lung Cancer; 2016 Dec; 102():122-134. PubMed ID: 27987580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry.
    Soo RA; Kubo A; Ando M; Kawaguchi T; Ahn MJ; Ou SI
    Clin Lung Cancer; 2017 Sep; 18(5):535-542. PubMed ID: 28433570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Former smokers with non-small-cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosis.
    Zheng S; Wang R; Zhang Y; Pan Y; Cheng C; Zheng D; Sun Y; Chen H
    Cancer Med; 2016 Aug; 5(8):2117-25. PubMed ID: 27227356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multigene Mutation Profiling and Clinical Characteristics of Small-Cell Lung Cancer in Never-Smokers vs. Heavy Smokers (Geno1.3-CLICaP).
    Cardona AF; Rojas L; Zatarain-Barrón ZL; Ruiz-Patiño A; Ricaurte L; Corrales L; Martín C; Freitas H; Cordeiro de Lima VC; Rodriguez J; Avila J; Bravo M; Archila P; Carranza H; Vargas C; Otero J; Barrón F; Karachaliou N; Rosell R; Arrieta O
    Front Oncol; 2019; 9():254. PubMed ID: 31058075
    [No Abstract]   [Full Text] [Related]  

  • 25. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.
    Mounawar M; Mukeria A; Le Calvez F; Hung RJ; Renard H; Cortot A; Bollart C; Zaridze D; Brennan P; Boffetta P; Brambilla E; Hainaut P
    Cancer Res; 2007 Jun; 67(12):5667-72. PubMed ID: 17575133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose.
    Li H; Pan Y; Li Y; Li C; Wang R; Hu H; Zhang Y; Ye T; Wang L; Shen L; Sun Y; Chen H
    Lung Cancer; 2013 Jan; 79(1):8-13. PubMed ID: 23098378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlative analysis of gene mutation and clinical features in patients with non-small cell lung cancer.
    Kuang X; Xiao J; Dai LX; Zhang LH; He BX
    Transl Cancer Res; 2019 Jun; 8(3):736-751. PubMed ID: 35116812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of smoking status on the progression-free survival of non-small cell lung cancer patients receiving molecularly target therapy or immunotherapy versus chemotherapy: A meta-analysis.
    Li X; Huang C; Xie X; Wu Z; Tian X; Wu Y; Du X; Shi L
    J Clin Pharm Ther; 2021 Apr; 46(2):256-266. PubMed ID: 33152129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal growth factor receptor mutations and their correlation with gefitinib therapy in patients with non-small cell lung cancer: a meta-analysis based on updated individual patient data from six medical centers in mainland China.
    Wu YL; Zhong WZ; Li LY; Zhang XT; Zhang L; Zhou CC; Liu W; Jiang B; Mu XL; Lin JY; Zhou Q; Xu CR; Wang Z; Zhang GC; Mok T
    J Thorac Oncol; 2007 May; 2(5):430-9. PubMed ID: 17473659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial DNA mutations in respiratory complex-I in never-smoker lung cancer patients contribute to lung cancer progression and associated with EGFR gene mutation.
    Dasgupta S; Soudry E; Mukhopadhyay N; Shao C; Yee J; Lam S; Lam W; Zhang W; Gazdar AF; Fisher PB; Sidransky D
    J Cell Physiol; 2012 Jun; 227(6):2451-60. PubMed ID: 21830212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidermal Growth Factor Receptor Mutation (EGFR) Testing for Prediction of Response to EGFR-Targeting Tyrosine Kinase Inhibitor (TKI) Drugs in Patients with Advanced Non-Small-Cell Lung Cancer: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(24):1-48. PubMed ID: 23074402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Never smokers with lung cancer: analysis of genetic variants.
    Xiao H; Ding J; Gao S; Yang S; Huang Y
    Asian Pac J Cancer Prev; 2011; 12(10):2807-9. PubMed ID: 22320997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of sex and smoking status on the mutational spectrum of epidermal growth factor receptor gene in non small cell lung cancer.
    Toyooka S; Matsuo K; Shigematsu H; Kosaka T; Tokumo M; Yatabe Y; Ichihara S; Inukai M; Suehisa H; Soh J; Kiura K; Fong KM; Lee H; Wistuba II; Gazdar AF; Mitsudomi T; Date H
    Clin Cancer Res; 2007 Oct; 13(19):5763-8. PubMed ID: 17908966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers.
    Seike M; Goto A; Okano T; Bowman ED; Schetter AJ; Horikawa I; Mathe EA; Jen J; Yang P; Sugimura H; Gemma A; Kudoh S; Croce CM; Harris CC
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12085-90. PubMed ID: 19597153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histological subtype and smoking status, but not gender, are associated with
    Hsiao SH; Lin SE; Chou YT; Wang JL; Chung CL; Yu MC; Fang CL; Lee HL; Chiang LL; Liu HE; Wu CW
    Mol Clin Oncol; 2014 Mar; 2(2):252-258. PubMed ID: 24649342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spectrum of germline mutations in smokers and non-smokers in Brazilian non-small-cell lung cancer (NSCLC) patients.
    Couto PP; Bastos-Rodrigues L; Schayek H; Melo FM; Lisboa RGC; Miranda DM; Vilhena A; Bale AE; Friedman E; De Marco L
    Carcinogenesis; 2017 Oct; 38(11):1112-1118. PubMed ID: 28968711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of active smoking on survival of patients with metastatic lung adenocarcinoma harboring an epidermal growth factor receptor (EGFR) mutation.
    Erdogan B; Kodaz H; Karabulut S; Cinkaya A; Tozkir H; Tanriverdi O; Cabuk D; Hacioglu MB; Turkmen E; Hacibekiroglu I; Uzunoglu S; Cicin I
    Bosn J Basic Med Sci; 2016 Nov; 16(4):280-285. PubMed ID: 27371767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of heavy smoking on the benefits from first-line EGFR-TKI therapy in patients with advanced lung adenocarcinoma.
    Zhang P; Nie X; Bie Z; Li L
    Medicine (Baltimore); 2018 Mar; 97(9):e0006. PubMed ID: 29489642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.
    Wu X; Cheng J; Yang K
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The genomic landscape of nonsmall cell lung carcinoma in never smokers.
    Boeckx B; Shahi RB; Smeets D; De Brakeleer S; Decoster L; Van Brussel T; Galdermans D; Vercauter P; Decoster L; Alexander P; Berchem G; Ocak S; Vuylsteke P; Deschepper K; Lambrechts M; Cappoen N; Teugels E; Lambrechts D; De Greve J
    Int J Cancer; 2020 Jun; 146(11):3207-3218. PubMed ID: 31745979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.